Aquatic Capital Management LLC Beam Therapeutics Inc. Transaction History

Aquatic Capital Management LLC

  • $3.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$21.22 - $32.66 $38,196 - $58,787
-1,800 Reduced 22.78%
6,100 $142,000
Q1 2024

May 15, 2024
BUY
$23.46 - $45.07 $185,334 - $356,053
7,900 New
7,900 $261,000
Q1 2023

May 15, 2023
BUY
$30.15 - $48.79 $262,305 - $424,473
8,700 Added 59.59%
23,300 $713,000
Q4 2022

Feb 14, 2023
BUY
$36.73 - $51.6 $536,258 - $753,360
14,600 New
14,600 $567,000

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email